CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
0.9489
+0.1039 (12.30%)
Aug 14, 2026, 4:00 PM EDT - Market closed
CytoMed Therapeutics Market Cap
CytoMed Therapeutics has a market cap or net worth of $11.23 million as of August 14, 2026. Its market cap has decreased by -44.40% in one year.
Market Cap
11.23M
Enterprise Value
9.97M
1-Year Change
-44.40%
Ranking
Category
Stock Price
$0.95
ChartMarket Cap Chart
Since the IPO on April 14, 2023, CytoMed Therapeutics's market cap has decreased from $46.12M to $11.23M, a decrease of -75.65%. That is a compound annual growth rate of -34.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 11.23M | -27.12% |
| Dec 31, 2025 | 15.41M | -60.74% |
| Dec 31, 2024 | 39.24M | -30.55% |
| Dec 29, 2023 | 56.49M | 22.50% |
| Apr 14, 2023 | 46.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 10.72M |
| Lunai Bioworks | 10.65M |
| Lisata Therapeutics | 10.63M |
| OSR Health | 10.15M |
| Lexaria Bioscience | 10.11M |
| BioCardia | 10.01M |
| IN8bio | 9.83M |
| CalciMedica | 9.79M |